Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Latest filing published 02 Jul 2025 for SpringWorks Therapeutics, Inc.. Read the official filing
Insider track record
Disclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Michael Nofi: trading record in brief
This profile gathers the share dealings of Michael Nofi in SpringWorks Therapeutics, Inc., where the filings describe the role as senior executive. Between 6 January 2022 and 1 July 2025, the trades on record add up to 9 filings.
None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
On 2 July 2025 came the latest disclosure, a transaction in SpringWorks Therapeutics, Inc. Typically, a trade is published a median of 4 days after it takes place. US insiders must file a Form 4 within two business days of a trade. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Michael Nofi
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations9 total
30,623 sharesCommon StockSEC:0001104659-25-065302:0
6,929 shares0Common StockSEC:0001104659-25-003466:0
2,388 shares@ US$38.1945.2% of flowCommon StockSEC:0001104659-25-001773:0
14,104 shares0Common StockSEC:0001104659-24-002376:0
409 shares@ US$26.415.2% of flowCommon StockSEC:0001104659-23-002719:0
9,713 sharesCommon StockSEC:0001104659-23-002314:0
414 shares@ US$56.0613.9% of flowCommon StockSEC:0001104659-22-004467:0
567 shares@ US$56.0619.0% of flowCommon StockSEC:0001104659-22-003145:0
5,748 sharesCommon StockSEC:0001104659-22-002739:0
9 of 9 declarations
